Anderson Benjamin M, Dutton Mary, Day Edward, Jackson Thomas A, Ferro Charles J, Sharif Adnan
Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Trials. 2018 Aug 24;19(1):457. doi: 10.1186/s13063-018-2842-x.
Frailty is a state of low physiological reserve and multi-systemic dysregulation that leads to susceptibility to external stressors; it is associated with adverse outcomes. North American data suggest that haemodialysis recipients are more likely to be frail than the general population, although data on UK cohorts are lacking. Furthermore, with a multitude of assessment tools, it is difficult for the clinician to ascertain which is most suitable for this population. The FITNESS Study aims to measure the prevalence and outcomes associated with frailty in a large UK haemodialysis cohort to determine the optimum frailty tool as defined by predictive value for mortality/hospitalisation and to conduct a feasibility study exploring a multi-disciplinary clinical intervention to improve frailty among haemodialysis recipients.
METHODS/DESIGN: The study will follow a cohort multiple randomised controlled trial design; the initial cohort study will identify participants to be invited into a subsequent open-label randomised controlled trial. Eligible patients will be identified and recruited from their usual haemodialysis session. They will be invited to complete tasks and questionnaires collecting data on sarcopenia, immunosenescence, mood, cognition, disability, and comorbidity. Fifty pre-frail participants with suitable English proficiency will be randomly selected from this cohort to participate in the randomised controlled trial phase of the study. Further stratified randomisation will occur to assign these 50 participants to active or passive groups. The active group will receive a psychologically supported, patient-centred, multi-disciplinary intervention into frailty, in what we believe to be a first within this patient group. The control group will receive usual haemodialysis standard of care. All participants will be followed up using electronic patient records for outcomes to include hospitalisation and mortality. Primary outcomes for this phase of the study will be feasibility and tolerability of the clinical intervention study.
The study will collect data on multiple aspects of frailty allowing for a rich dataset for detailed analysis. We believe this will be the first study to explore a psychologically supported, patient-centred intervention in this patient group.
Clinicaltrials.gov, NCT03071107 . Registered on 6 March 2017.
衰弱是一种生理储备低下和多系统失调的状态,会导致对外界应激源的易感性增加,且与不良后果相关。北美数据表明,血液透析患者比普通人群更易衰弱,不过缺乏英国队列的数据。此外,由于评估工具众多,临床医生难以确定哪种最适合该人群。FITNESS研究旨在测量英国一个大型血液透析队列中衰弱的患病率及相关后果,以确定由死亡率/住院预测值定义的最佳衰弱评估工具,并开展一项可行性研究,探索多学科临床干预措施以改善血液透析患者的衰弱状况。
方法/设计:本研究将采用队列多重随机对照试验设计;初始队列研究将确定受邀参加后续开放标签随机对照试验的参与者。符合条件的患者将在其常规血液透析时段被识别并招募。他们将被邀请完成收集肌肉减少症、免疫衰老、情绪、认知、残疾和合并症数据的任务及问卷。将从该队列中随机选取50名具备适当英语能力的衰弱前期参与者参加研究的随机对照试验阶段。还将进行进一步分层随机化,将这50名参与者分配到主动或被动组。主动组将接受针对衰弱的心理支持、以患者为中心的多学科干预,我们认为这在该患者群体中尚属首次。对照组将接受常规血液透析标准护理。所有参与者将通过电子病历进行随访,以获取包括住院和死亡在内的结局数据。本研究此阶段的主要结局将是临床干预研究的可行性和耐受性。
本研究将收集关于衰弱多个方面的数据,从而形成一个丰富的数据集以供详细分析。我们认为这将是第一项探索针对该患者群体进行心理支持、以患者为中心干预的研究。
Clinicaltrials.gov,NCT03071107。于2017年3月6日注册。